Scott Daniel Cormack, President and CEO at ONCOGENEX PHARMACEUTICALS, INC. (OGXI), sold 18,660 shares at $16.52 ($165K) on 2011-01-04, disclosed to the SEC on 2011-01-06.
Scheduled sale ($165k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.52 | 3,392 | $56K | 33.9% |
| 2 | $16.52 | 6,608 | $109K | 66.1% |
| 3 | $0.00 | 8,660 | $0 | 0.0% |
| Total | $8.85 avg | 18,660 | $165K | 100% |
| Filing → |
| OGXI | SELL | 2015-06-16 | $12K | — | Filing → |
| OGXI | SELL | 2015-05-21 | $14K | — | Filing → |
| OGXI | SELL | 2014-08-14 | $58K | — | Filing → |